Aileron Therapeutics Inc (ALRN)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -129.631 | -60.622 | -76.017 | -103.439 | -98.832 | -80.726 | -77.542 | -24.578 |
Return on Equity (%) | 17.584 | 70.756 | -93.615 | -164.772 | -149.996 | -93.333 | -87.415 | -26.911 |
Return on Invested Capital (%) | 17.426 | 70.206 | -97.476 | -177.082 | -147.13 | -94.577 | -88.5 | -22.458 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -26.02 | 3.246 | 1.329 | 0.577 | 0.278 | 0.485 | 0.205 | -17.224 |
Earnings Per Share | -4.218 | -1.538 | -2.139 | -1.056 | -0.483 | -0.289 | -0.301 | -3.445 |
Cash Per Share | 4.821 | 0.806 | 0.721 | 0.191 | 0.161 | 0.04 | 0.057 | 3.792 |
Working Capital Per Share | 3.957 | 3.189 | 1.112 | 0.493 | 0.282 | 0.482 | 0.204 | 3.04 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -4.218 | -1.535 | -2.139 | -1.056 | -0.483 | -0.289 | -0.301 | -3.445 |
EBITDA Per Share | -4.218 | -1.535 | -2.139 | -1.056 | -0.483 | -0.289 | -0.301 | -3.445 |
Free Cash Flow Per Share | -4.272 | -1.535 | -1.854 | -1.056 | -0.487 | -0.288 | -0.303 | -3.472 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 4,3M | 14,72M | 14,75M | 27,81M | 43,8M | 90,57M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 38,13M |
Ratio cours/bénéfice | -2,44 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 2,21 |
Ratio prix/valeur comptable | 0,39 |
Rendement de dividende | - |
Actions en circulation | 21,67M |
Volume moyen (1 semaine) | 126,69k |
Volume moyen (1 mois) | 89,21k |
Variation sur 52 semaines | -46,81% |
Plus haut sur 52 semaines | 7,42 |
Plus bas sur 52 semaines | 1,61 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales